Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$4.56 0.06 (1.33%)
2/9/2010 4:00 PM

Acura Pharmaceuticals Inc. (ACUR)

CAPS Rating:
*

A pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) Technology and related product candidates.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating ACUR

Add Stock to Watchlist

What the Community Thinks

Acura Pharmaceuticals Inc. At A Glance

Current Price: $4.56
Last Trade Time: 2/9/2010 4:00 PM
Open: $4.55
Previous Close: $4.50
Daily Range: $4.50 - $4.65
52-Week Range: $4.00 - $9.00
Volume: 14,355
Market Cap: $195.94M
P/E Ratio: 44.85
Compare Our Special Broker Offers!

Stock Trends

ACUR VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

1

Acura Pharmaceuticals Inc. (ACUR)

Avatar davidr825 (< 20) Submitted: 6/13/08 7:58 PM

Unique delivery of controlled substances will make this a winner - especially when coupled with King Pharmaceutical

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Acura Pharmaceuticals Inc. (ACUR)

Avatar tcampbellla (90.80) Submitted: 10/29/07 3:16 PM

No thanks.

Replies: 4 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 9 :   1 2 Next »

Recs

0

 (ACUR)

Avatar steelersnextat7 (< 20) Submitted: 9/22/09 2:10 AM : Outperform Start Price: $4.88 ACUR Score: -6.69

FDA approval is looming in Jan to March 2010 when it does acura will hit 12 to 15 or be bought or both king will scoop it up

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ACUR)

Avatar TSIF (98.89) Submitted: 6/29/09 10:18 PM : Outperform Start Price: $6.01 ACUR Score: -44.60

Acura Pharmaceuticals got bloodied (36%) when it received word from the FDA that it had a "labeling" issue for it's experimental pain drug Acurox which would delay a response past the expected June 30th date. While this could be bad news, as it adds another layer to the process and delays, it appears to me to be as expected for a drug that includes oxycodone WHILE trying to meet the new FDA guidelines that attempt to curb prescription drug abuse, which can be common with opioid pain drugs. Acura's "Aversion(r)" (abuse deterrent) Technology, has the issue of being the first to test the new guidelines and it should not be unexpected for the FDA to ensure they are establishing a clear set of guidelines. Once through these hurdles Acura will be the "poster child" for the new rules and will be able to see it's drug where other companies cannot without similar approval. Several analysts expect the dreaded "complete response" letter from the FDA which could set things back 6-18 months if more data is needed, but this delay to me appears to only be a cautious approach from the FDA, not a formal "complete response". If I'm wrong, my CAPs will need some pain reliever!

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ACUR)

Avatar TLassen (64.56) Submitted: 3/21/09 1:24 PM : Outperform Start Price: $5.66 ACUR Score: -44.91

Ticker Symbol          ACUR   
Name of Company         ACURA PHARMACEUTICAL   
Date          March 1, 2009   
Earnings Report (Qtr/YR)      4TH QTR 2008   
   
Strategic Score          71%   

Intrinsic Value          $5.21
Buy at (Based on MOS)      $3.18   
Sell Profits (Based on MOS)   $8.12   
Premium or (discount) MOS   1%   
10 year Bond (risk free)      2.80%   
Premium           5.00%   
Discount Rate          7.80%   
Growth (Retention Model)      39.05%   
Margin of Safety          39%

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ACUR)

Avatar manvsmonkey (74.66) Submitted: 7/28/08 2:09 PM : Outperform Start Price: $7.30 ACUR Score: -26.60

seems like the phase III trial is going well

http://seekingalpha.com/article/87373-a-biotech-bloom-in-july?source=side_bar_long_ideas

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ACUR)

Avatar rvood (< 20) Submitted: 7/23/08 12:25 AM : Outperform Start Price: $7.67 ACUR Score: -26.98

New Aversion technology, phase 3 appears to be going well, licensing agreements in place, R&D being paid for by King, low float, pipeline ever increasing, starting to get looked at by funds, etc, too many druggies out there, what's not to like.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 9 :   1 2 Next »

Wall Street

There are no Wall Street tracker picks.

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD04 421ms